Registry of Lobbyists
Version 2 of 65 (1997-02-04 to 1998-02-13) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
GLAXOSMITHKLINE
7333 MISSISSAUGA ROAD NORTH MISSISSAUGA, ON L5N 6L4 Canada |
| Telephone number: | 905-819-3030 |
| Fax number: | 905-819-3097 |
| Responsible officer name and position during the period of this registration: | PAUL N LUCAS, PRESIDENT & CEO |
| Description of activities: | GLAXO WELLCOME INC. IS ONE OF CDA'S LARGEST RESEARCH-BASED PHARMACEUTICAL CIES. IT'S BRITISH PARENT, GLAXO PLC, AMALGAMATED WITH WELLCOME PLC IN MARCH, 1995 TO CREATE THE WORLD'S LARGEST RESEARCH-BASED PHARMACEUTICAL CIE.GLAXO WELLCOME OPERATES 3 MAIN FACILITIES IN CD, INCLUDING ITS BUREAU D'AFFAIRES DU QUEBEC IN MONTREAL, AND EMPLOYS MORE THAN 1100 PEOPLE ACROSS THE COUNTRY.GLAXO WELLCOME IS A LEADER IN MANY IMPORTANT THERAPEUTIC AREAS, INCLUDING CARDIOVASCULAR, HIV/ AIDS, GASTRO-INTESTINAL, RESPIRATORY DISEASES & ANTI-INFECTIVE.GLAXO WELLCOME INVESTS MORE THAN $50 MILLION IN RESEARCH & DEV. IN CDA ANNUALLY. IN ADDITION, GLAXO WELLCOME CONDUCTS ALMOST $10 MILLION IN CLINICAL RESEARCH ANNUALLY TO EVALUATE DRUGS FOR AIDS, ASTHMA, MIGRAINE, INFLUENZA, NAUSEA & VOMITING.GLAXO WELLCOME'S MANUFACTURING OPERATIONS SERVE BOTH CDN & AMERICAN MARKETS.GLAXO WELLCOME'S MISSISSAUGA HQ WERE COMPLETED IN 91. THIS MARKED THE 1ST PHASE OF A MULTI-MILLION $ EXPANSION, INCLUDING A STATE OF THE ART MANUFACTURING PLANT, DUE TO OPEN IN 97. |
| Parent: | The corporation is not a subsidiary of any other parent corporations. |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Aboriginal Affairs and Northern Development Canada, Environment Canada, Federal Environmental Assessment Review Office (FEARO), Federal Office of Regional Development – Quebec (FORD[Q]), Finance Canada (FIN), Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Human Resources Development Canada (HRDC), Industry Canada, Patented Medicine Prices Review Board (PMPRB), Social Sciences and Humanities Research Council (SSHRC), Treasury Board Of Canada Secretariat (TBS), Western Economic Diversification Canada (WD) |
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Grass-roots communication, Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format |
| Subject Matter: Areas of Concern: | Consumer Issues, Employment and Training, Environment, Health, Industry, Intellectual Property, International Relations, International Trade, Regional Development, Science and Technology, Taxation and Finance |
| Subject Matter: Particulars: | ANY LEGISLATIVE PROPOSALS, POLICIES OR PAPERS, BILLS OR RESOLUTIONS, OR REGULATIONS THAT WOULD IMPACT THE BRAND NAME PHARMACEUTICAL INDUSTRY OR THE REVIEW OF ANY PATENT LEGISLATION, INCLUDING BILL C-91. |
This is the responsible officer name as provided in the most recent registration for the corporation or organization.
| Name | From | To |
|---|---|---|
| GlaxoSmithKline | 2024-04-01 | current |
| GlaxoSmithKline | 2008-07-09 | 2024-04-01 |
| Responsible Officer Name | From (YYYY-MM-DD) | To (YYYY-MM-DD) |
|---|---|---|
| Sridhar Venkatesh | 2022-12-01 | Current |
| Zach Gana | 2022-07-18 | 2022-12-01 |
| Faris El-Refaie | 2020-09-01 | 2022-07-18 |
| Yoo-Seok Hong | 2018-03-01 | 2020-09-01 |
| Josee Gravelle | 2018-02-01 | 2018-03-01 |
| Paul Lirette | 2012-06-15 | 2018-02-01 |
| Paul Lucas | 1996-03-25 | 2012-06-15 |
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.